Sepsis in the tropical top end of Australia's Northern territory: Disease burden and impact on indigenous Australians

Medical Journal of Australia

Volumn 194, Issue 10, 2011, Pages 519-524

  Davis, Joshua S ^a,b   Cheng, Allen C ^b,c,d   McMillan, Mark ^b   Humphrey, Alex B ^b   Stephens, Dianne P ^a   Anstey, Nicholas M ^a,b  

^a ROYAL DARWIN HOSPITAL   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN;

ABDOMINAL INFECTION; ACINETOBACTER; ADULT; AGE; ALBUMIN BLOOD LEVEL; ALPHA HEMOLYTIC STREPTOCOCCUS; ANAEROBIC BACTERIUM; APACHE; ARTICLE; AUSTRALIA; BETA HEMOLYTIC STREPTOCOCCUS; BURKHOLDERIA PSEUDOMALLEI; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS; HOSPITAL ADMISSION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INDIGENOUS PEOPLE; INFLUENZA VIRUS; INTENSIVE CARE UNIT; KIDNEY FAILURE; KLEBSIELLA; LIFE SUSTAINING TREATMENT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MIXED INFECTION; MORTALITY; MULTIDRUG RESISTANT METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEISSERIA GONORRHOEAE; NEOPLASM; PNEUMONIA; POPULATION RESEARCH; PROSPECTIVE STUDY; PROTEUS; PSEUDOMONAS; RESIDENTIAL CARE; RISK FACTOR; SCORING SYSTEM; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SHIGELLA; SKIN INFECTION; SOFT TISSUE INFECTION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS MILLERI; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URBAN POPULATION;

EID: 79957945589     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2011.tb03088.x     Document Type: Article

References (29)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
2. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.
3. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34: 344-353.
4. Padkin A, Goldfrad C, Brady AR, et al. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31: 2332-2338.
5. Finfer S, Bellomo R, Lipman J, et al. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004; 30: 589-596.
6. French CJ. The epidemiology of sepsis - is Australasia different? Crit Care Resusc 2006; 8: 219-222.
7. Blumer C, Roche P, Spencer J, et al. Australia's notifiable diseases status, 2001: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2003; 27: 1-78.
8. Zhao Y, Connors C, Wright J, et al. Estimating chronic disease prevalence among the remote Aboriginal population of the Northern Territory using multiple data sources. Aust N Z J Public Health 2008; 32: 307-313.
9. Gracey M, King M. Indigenous health part 1: determinants and disease patterns. Lancet 2009; 374: 65-75.
10. Flaatten H. Epidemiology of sepsis in Norway in 1999. Crit Care 2004; 8: R180-R184.
11. Ollendorf DA, Fendrick AM, Massey K, et al. Is sepsis accurately coded on hospital bills? Value Health 2002; 5: 79-81.
12. Australian Bureau of Statistics. Northern Territory - SSD by Indigenous status and age, from 2006 census of population and housing. Canberra: ABS, 2007.
13. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/ SCCM Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
14. Davis JS, Cross GB, Charles PG, et al. Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply? Med J Aust 2010; 192: 133-136.
15. Bernard GR, Vincent JL, Laterre PF, et al; Recom-binant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
16. Australian Bureau of Statistics. Population by age and sex, Australian states and territories, Jun 2007. Canberra: ABS, 2007. (ABS Cat. No. 3201.0.)
17. Australian Bureau of Statistics. Australia's standard population. Australian demographic statistics, September quarter 2002. Canberra: ABS. 2003. (ABS Cat. No. 3101.0.) http:// www.aihw.gov.au/publications/aus/ah08/ah08-x02.rtf (accessed Feb 2011).
18. Australian Department of Health and Aged Care. Measuring remoteness: Accessibility/Remoteness Index of Australia (ARIA). Canberra: Commonwealth of Australia, 2001. http:// www.health.gov.au/internet/main/publish-ing.nsf/Content/7B1A5FA525DD0D39CA2574 8200048131/$File/ocpanew14.pdf (accessed Feb 2011).
19. National Health and Medical Research Council. Australian alcohol guidelines: health risks and benefits. Canberra: NHMRC, 2001.
20. Charlson M, Szatrowski T P, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-1251.
21. Sundararajan V, Macisaac CM, Presneill JJ, et al. Epidemiology of sepsis in Victoria, Australia. Crit Care Med 2005; 33: 71-80.
22. Brun-Buisson C, Meshaka P, Pinton P, et al. EPI-SEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30: 580-588.
23. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-797.
24. Rubulotta F, Marshall JC, Ramsay G, et al. Predisposition, insult/infection, response, and organ dysfunction: a new model for staging severe sepsis. Crit Care Med 2009; 37: 1329-1335.
25. Martin CM, Priestap F, Fisher H, et al. A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med 2009; 37: 81-88.
26. Torzillo PJ, Pholeros P, Rainow S, et al. The state of health hardware in Aboriginal communities in rural and remote Australia. Aust N Z J Public Health 2008; 32: 7-11.
27. McDonald MI, Towers RJ, Andrews RM, et al. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian Aboriginal communities where acute rheumatic fever is hyperen-demic. Clin Infect Dis 2006; 43: 683-689.
28. Stephens D P, Thomas JH, Higgins A, et al. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock. Crit Care Med 2008; 36: 448-454.
29. Davis JS, Yeo TW, Thomas JH, et al. Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study. Crit Care 2009; 13: R155.